Evidence map›Paper›PMID 14612426›Full record

ArticleMolecular and cellular biology2003

The transcriptional repressor HBP1 is a target of the p38 mitogen-activated protein kinase pathway in cell cycle regulation.

Mei Xiu, Jiyoung Kim, Ellen Sampson, Chun-Yin Huang, Roger J Davis, K Eric Paulson, Amy S Yee

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. P16INK4A-More Than a Senescence Marker.Life (Basel, Switzerland) · 2022
    Review
  4. Article
  5. HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression.Journal of experimental & clinical cancer research : CR · 2021
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. HMGB1 in health and disease.Molecular aspects of medicine · 2014
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Cellular senescence and tumor suppressor gene p16.International journal of cancer · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mei XiuDepartment of Biochemistry, School of Medicine, Tufts University, Boston, Massachusetts 02111, USA.
Jiyoung Kim
Ellen Sampson
Chun-Yin Huang
Roger J Davis
K Eric Paulson
Amy S Yee
Tufts University · USUniversity of Massachusetts Chan Medical School · US

Funding

PILOT AND FEASIBILITY STUDIESP30DK034928 · NIDDK · TUFTS MEDICAL CENTER · PI PLAUT, ANDREW GEORGE · 1986 to 2007
$8.5M
Mechanisms of Transcriptional Repressor HBP1 in CancerR01CA094187 · NCI · TUFTS UNIVERSITY BOSTON · PI YEE, AMY S. · 2002 to 2006
$1.4M
TRANSCRIPTIONAL REPRESSION AND CELL CYCLE MECHANISMSR01GM044634 · NIGMS · TUFTS UNIVERSITY BOSTON · PI YEE, AMY S. · 1991 to 2000
$363k
p38 MAP Kinase/HBP1 Regulation of Reactive Oxygen Speci*R03ES011518 · NIEHS · TUFTS UNIVERSITY BOSTON · PI PAULSON, KURTZ ERIC · 2001 to 2002
$159k
NCI NIH HHS CA94187NCI NIH HHS R01 CA094187NIDDK NIH HHS P30 DK034928NIDDK NIH HHS P30 DK34928NIEHS NIH HHS ES11518NIGMS NIH HHS GM44634
6 · The paper itself

Abstract

The p38 mitogen-activated protein (MAP) kinase signaling pathway participates in both apoptosis and G1 arrest. In contrast to the established role in apoptosis, the documented induction of G1 arrest by activation of the p38 MAP kinase pathway has attracted recent attention with reports of substrates that are linked to cell cycle regulation. Here, we identify the high-mobility group box protein HBP1 transcriptional repressor as a new substrate for p38 MAP kinase. Our previous work had shown that HBP1 inhibits G1 progression in cell and animal models, and thus indicated that HBP1 could be a relevant substrate for p38 MAP kinase in cell cycle regulation. In the present work, a p38 MAP kinase docking site (amino acids [aa] 81 to 125) and a p38 MAP kinase phosphorylation site (serine 401) were identified in the HBP1 protein. Furthermore, the docking and phosphorylation sites on HBP1 were specific for p38 MAP kinase. In defining the role of p38 MAP kinase regulation, the inhibition of p38 MAP kinase activity was shown to decrease HBP1 protein levels by triggering protein instability, as manifested by a decrease in protein half-life. Consistently, a decrease in protein levels was accompanied by a decrease in overall DNA binding activity. A mutation of the p38 MAP kinase phosphorylation site at aa 401 [(S-A)401HBP1] also triggered HBP1 protein instability. While protein stability was compromised by mutation, the specific activities of (S-A)401HBP1 and of wild-type HBP1 appeared comparable for transcriptional repression. This comparison of transcription-specific activity highlighted that p38 MAP kinase regulated HBP1 protein levels but not the intrinsic activity for DNA binding or for transcriptional repression. Finally, p38 MAP kinase-mediated regulation of the HBP1 protein also contributed to the regulation of G1 progression. Together, our work supports a molecular framework in which p38 MAP kinase activity contributes to cell cycle inhibition by increasing HBP1 and other G1 inhibitory factors by regulating protein stability.

Indexed as

AnimalsBase SequenceCell CycleDNA, ComplementaryG1 PhaseHigh Mobility Group ProteinsIn Vitro TechniquesMaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, TransgenicMitogen-Activated Protein KinasesModels, BiologicalMutagenesis, Site-Directedp38 Mitogen-Activated Protein KinasesDNA, ComplementaryHbp1 protein, mouseHigh Mobility Group ProteinsMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesRecombinant ProteinsRepressor ProteinsRNA, Messenger

Identifiers

PMID14612426
PMCPMC262665
OpenAlexW2144977132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.